https://www.marketscreener.com/quote/stock/HALOZYME-THERAPEUTICS-INC-50245/news/Halozyme-Announces-Takeda-Receives-FDA-Approval-for-HYQVIA-Co-formulated-with-ENHANZE-as-Mainten-45748186/?utm_source=telegram&utm_medium=social&utm_campaign=share